Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2013
05/22/2013CN102190628B Preparation method of 5-fluoro-6-ethyl-4-hydroxypyrimidine intermediate and Voriconazole
05/22/2013CN102134214B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
05/22/2013CN101959969B Azo pigment composition, process for production of the composition, dispersions containing the composition, colored compositions and jet printing ink
05/22/2013CN101903359B Triazole-substituted arylamide derivatives and their use as P2X3 and /or P2X2/3 purinergic receptor antagonists
05/22/2013CN101821257B 5-HT7 receptor antagonists
05/22/2013CN101528713B Pyridazine derivatives used as 11 beta-hydroxysteroid dehydrogenase type 1 inhibitors
05/22/2013CN101479250B Tetrazole-substituted arylamides
05/22/2013CN101316823B 2,4,5-triphenyl imidazoline derivatives as inhibitors of interaction between p53 and MDM2 proteins for use as anticancer agents
05/21/2013US8445694 Hydrazonopyrazole derivatives and their use as therapeutics
05/21/2013US8445679 7-substituted indole MCL-1 inhibitors
05/21/2013US8445525 Carboxylic acid amides, the preparation thereof and their use as medicaments
05/21/2013US8445505 Pyrimidine derivatives as kinase inhibitors
05/21/2013US8445491 Wnt protein signalling inhibitors
05/21/2013US8445477 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/21/2013US8445473 Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof
05/21/2013US8444879 Triazine derivatives
05/21/2013CA2587678C Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
05/21/2013CA2560162C Inhibitors of iap
05/21/2013CA2428753C Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
05/16/2013WO2013071217A1 Dihydropteridinones
05/16/2013WO2013071203A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
05/16/2013WO2013071090A1 Compounds useful as inhibitors of atr kinase
05/16/2013WO2013071088A1 Compounds useful as inhibitors of atr kinase
05/16/2013WO2013071067A1 Phenyl-substituted nicotinic ligands, and methods of use thereof
05/16/2013WO2013070660A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
05/16/2013WO2013070659A1 Modulators of opioid receptors and methods of use thereof
05/16/2013WO2013070107A1 5h-dibenzo[b,e][1,4]diazepine derivatives and use thereof
05/16/2013WO2013069771A1 Anthranilic acid derivative and noxious organism control agent
05/16/2013WO2013068875A1 2-thiopyrimidinones
05/16/2013WO2013068769A1 Pharmaceutical compounds
05/16/2013WO2013068554A1 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013WO2013068552A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
05/16/2013WO2013068463A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an n-cyclic group as vanilloid receptor ligands
05/16/2013WO2013068328A1 Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors
05/16/2013WO2013067578A1 Modulators of c3a receptors
05/16/2013WO2012054721A8 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
05/16/2013US20130123511 Process for the direct preparation of malic acid salt of sunitinib
05/16/2013US20130123507 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
05/16/2013US20130123500 Ethinyl-pyrazole derivative
05/16/2013US20130123493 Process for the synthesis of substituted urea compounds
05/16/2013US20130123315 Substituted imidazolones, compositions containing such compounds and methods of use
05/16/2013US20130123297 Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative
05/16/2013US20130123289 Certain amino-pyrimidines, compositions thereof, and methods for their use
05/16/2013US20130123286 Novel Fused Heterocyclic Derivatives Useful as c-Met Tyrosine Kinase Inhibitors
05/16/2013US20130123284 Heterocyclic compounds useful for kinase inhibition
05/16/2013US20130123281 Compositions and Methods for Inhibition of TBL-1 Binding to Disease-Associated Molecules
05/16/2013US20130123270 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
05/16/2013US20130123265 Compounds that modulate intracellular calcium
05/16/2013US20130123260 Methods
05/16/2013US20130123257 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
05/16/2013US20130123244 Hetero-Bicyclic Derivatives as HCV Inhibitors
05/16/2013US20130123243 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
05/16/2013US20130123232 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2013US20130123230 2-Thiopyrimidinones
05/16/2013US20130123215 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
05/16/2013US20130121957 Hepatitis C Virus Inhibitors
05/16/2013US20130118570 Dye for photoelectric conversion, semiconductor electrode, photoelectric conversion element, solar cell, and novel pyrroline-based compound
05/16/2013CA2855390A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
05/16/2013CA2855204A1 Pharmaceutical compounds
05/16/2013CA2854836A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
05/16/2013CA2854622A1 Modulators of opioid receptors and methods of use thereof
05/16/2013CA2853024A1 2-thiopyrimidinones
05/16/2013CA2849872A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013CA2849868A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/15/2013EP2592078A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592077A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592070A2 Tetrazole-substituted arylamides
05/15/2013EP2590978A2 Carbapenem antibacterials with gram-negative activity
05/15/2013EP2590966A1 Quinazoline compounds
05/15/2013EP2590965A2 Compounds and methods for inhibiting phosphate transport
05/15/2013EP2590960A1 Heterocyclic antiviral compounds
05/15/2013EP2590953A1 Tetrazole compounds as calcium channel blockers
05/15/2013EP2590952A1 1,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and intermediate thereof
05/15/2013EP2590951A1 Benzenesulfonamides useful as sodium channel inhibitors
05/15/2013EP2590655A1 Compounds and methods for inhibiting phosphate transport
05/15/2013EP2590647A2 Pro-neurogenic compounds
05/15/2013EP2127652B1 Method for treating cancer using anticancer agent in combination
05/15/2013CN103102352A Tyrosine kinase inhibitor indolinone derivative
05/15/2013CN103102348A Oxadiazole compound and preparation method thereof, medicine composition and application thereof
05/15/2013CN103102345A Aminoquinazoline derivative, salts thereof and application method
05/15/2013CN103102344A Aminoquinazoline derivative, salts thereof and application method
05/15/2013CN103102342A Aminoquinazoline derivative, salts thereof and application method
05/15/2013CN102076671B Triazole derivative or salt thereof
05/15/2013CN101772494B 4-pyrimidinesulfamide derivative
05/14/2013US8440837 2-substituted-ethynylthiazole derivatives and uses of same
05/14/2013US8440822 Sulfonyl amide derivatives for the treatment of abnormal cell growth
05/14/2013US8440678 Pharmaceutical composition
05/14/2013CA2731368C 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
05/14/2013CA2583333C Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
05/14/2013CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
05/10/2013WO2013067423A1 Pak inhibitors for the treatment of cell proliferative disorders
05/10/2013WO2013065835A1 Pharmaceutical composition for treating diabetes
05/10/2013WO2013064518A1 Pesticidal compounds
05/10/2013WO2013064451A1 Novel process for the preparation of acylguanidines and acylthioureas
05/10/2013WO2013040013A3 Bimetallic catalysts for co2 hydrogenation and h2 generation from formic acid and/or salts thereof
05/10/2013WO2013025736A3 Dendron reporter molecules
05/10/2013WO2013006308A3 Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders
05/10/2013WO2012178015A3 Lrrk2 inhibitors
05/10/2013WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
05/10/2013CA2854471A1 Pak inhibitors for the treatment of cell proliferative disorders
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 626